TABLE 3.
Medication | Mechanism of action | Site of kidney damage | Nephrotoxicity | Notes |
Acyclovir | Inhibits DNA synthesis and viral replication via inhibition of viral DNA polymerase | Tubule | Crystallization and obstruction occur causing tubular damage, particularly when in low urinary flow state | Can be used for prophylaxis (CMV, HSV, varicella, herpes zoster), suppression (HSV), and treatment (varicella zoster, herpes zoster, HSV, varicella). Dosage adjustment for renal impairment available (93). |
Amikacin | Inhibits protein synthesis via binding to 30S ribosomal subunits | Proximal tubule, S1 and S2 segments, late changes in S3 | Proximal tubular damage after accumulation of aminoglycoside | Dosage adjustment for renal impairment as well as augmented renal clearance available (93). |
Amphotericin B | Disrupts fungal cell wall synthesis and cell membrane permeability via binding to ergosterol which causes leakage of cellular components and subsequent cell death | Distal tubule | Vasoconstriction and direct distal tubular toxicity | Hydration and sodium repletion prior to administration of amphotericin B may reduce risk of renal toxicity. Dosage adjustment for renal impairment available (93). |
Gentamicin | Disrupts bacterial protein synthesis and cell membrane integrity via biding to 30S ribosomal subunit | Proximal tubule, S1 and S2 segments, late changes in S3 | Proximal tubular damage after accumulation of aminoglycoside | Dosage adjustment for renal impairment available (93). |
Indomethacin | Non-selective cyclooxygenase inhibitor decreasing prostaglandin synthesis | Afferent arteriole | Hemodynamically mediated: causes afferent arteriole vasoconstriction and reduced GFR | Dosage adjustment for renal impairment available (93). |
Piperacillin/Tazobactam | Inhibits bacterial cell wall synthesis leading to bacteria lysis | Tubule, particularly proximal tubule | Inhibits tubular secretion and clearance, direct toxicity | Dosage adjustment for renal impairment available (93). |
Vancomycin | Inhibits cell wall synthesis of gram-positive bacteria via blocking glycol-peptide polymerization | Proximal tubule | Direct toxicity, otherwise unclear | Dosage adjustment for renal impairment available (93). |
DNA, deoxyribonucleic acid; CMV, cytomegalovirus; HSV, herpes simplex virus; GFR, glomerular filtration rate.